GeneExcel

company

About

GeneExcel is engaged in the R&D and deployment of liposome technologies for the treatment of cancer, HIV, and cardiovascular diseases.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$700K
Industries
Biotechnology,Manufacturing
Founded date
Jan 1, 2002
Number Of Employee
1 - 10
Operating Status
Active

GeneExcel engages in the discovery, design, development, and deployment of liposome technologies. Its technologies are utilized for the treatment of cancer, cardiovascular diseases, and HIV-1-related diseases. The company also provides contract manufacturing services for customized systemic liposome products. Gene Excel was founded in 2002 and is based in Houston, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$700K
GeneExcel has raised a total of $700K in funding over 2 rounds. Their latest funding was raised on Mar 15, 2005 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 15, 2005 Series A $700K 1 ITX International Holdings Detail

Investors

Number of Lead Investors
Number of Investors
1
1
GeneExcel is funded by 1 investors. ITX International Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
ITX International Holdings Yes Series A